Aller au contenu principal
2022 conference-abstract

Transcription Factor Foxp2 Promotes TGF-β1-Induced Kidney Fibrosis in Obstructive Nephropathy

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : hk. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background: Forkhead Box P2 protein (Foxp2) is a transcription factor involved in multiple biological activities including organ development, tissue injury and tumor growth. Recent studies showed that Foxp2 regulates epithelial-mesenchymal transition (EMT) during tumorigenesis. Given that EMT is a crucial process in kidney fibrosis, we aim to investigate whether Foxp2 has a functional role in the progression of chronic kidney disease. Methods: Foxp2 expression was evaluated in cultured tubular epithelial cells (C1.1) treated with TGF-β1 (10ng/mL). Foxp2 was knocked down by siRNA prior to TGF-β1 stimulation. Tubule-specific Foxp2 knockout (Ksp-Foxp2 KO) mice and wild type control (WT) were generated by Cre-LoxP strategy and subjected to unilateral ureteral obstruction (UUO). Kidneys were collected at day 7 after UUO for the assessment of kidney fibrosis by real-time qPCR, Western blotting and immunohistochemical staining. Results: In C1.1 cells, FoxP2 expression was significantly induced by TGF-β1, which was partly inhibited by Smad3-specific inhibitor. Knocking down FoxP2 significantly suppressed the expression levels of TGF-β1-induced fibrotic markers collagen 1, PAI-1 and restored the loss of epithelial marker E-cadherin. In the UUO kidneys, TGF-β1 expression level was lower in Ksp-Foxp2 KO group compared to that of WT. Collagen deposition and expression of fibrosis markers fibronectin and PAI-1, and macrophage infiltration were greatly reduced in UUO kidneys from Foxp2 KO compared to WT group. Conclusions: Foxp2 promotes TGF-β1-induced EMT and fibrotic changes in obstructed kidneys and may become a novel therapeutic target for kidney fibrosis. Fundings: Research Grants Council of Hong Kong (General Research Fund, grant no.17108719) and Hong Kong Society of Nephrology/Hong Kong Kidney Foundation Research Grant 2020

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Transcription Factor Foxp2 Promotes TGF-β1-Induced Kidney Fibrosis in Obstructive Nephropathy
Date Crossref
01/11/2022
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Chronic Kidney Disease and DiabetesRenal and Vascular Pathologies

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.